Piero Picci Selected Research

Epirubicin (Ellence)

1/2017	Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
11/2015	Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piero Picci Research Topics

Disease

96	Neoplasms (Cancer) 01/2022 - 03/2002
84	Osteosarcoma (Osteogenic Sarcoma) 02/2023 - 01/2002
46	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 12/2002
45	Ewing Sarcoma (Sarcoma, Ewing) 06/2021 - 03/2002
36	Neoplasm Metastasis (Metastasis) 02/2023 - 03/2002
15	Necrosis 01/2022 - 01/2004
8	Giant Cell Tumor of Bone 01/2021 - 01/2011
7	Chondrosarcoma 10/2020 - 12/2005
7	Disease Progression 11/2018 - 12/2005
5	Margins of Excision 12/2016 - 03/2006
5	Rhabdomyosarcoma 08/2014 - 03/2002
4	Synovial Sarcoma (Synovioma) 01/2017 - 01/2014
3	Neurofibrosarcoma (MPNST) 01/2020 - 01/2015
3	Giant Cell Tumors (Giant Cell Tumor) 11/2018 - 01/2011
2	Thrombocytopenia (Thrombopenia) 10/2018 - 01/2017
2	Neutropenia 10/2018 - 01/2017
2	Spontaneous Fractures (Pathological Fracture) 10/2016 - 03/2006
2	Carcinogenesis 09/2015 - 09/2002
2	Breast Neoplasms (Breast Cancer) 03/2015 - 06/2004
2	Second Primary Neoplasms (Neoplasms, Second) 12/2006 - 10/2005
1	Neurofibroma 11/2023
1	Insulinoma 03/2021
1	Fibrosarcoma 01/2021
1	Pain (Aches) 01/2021
1	Malignant Fibrous Histiocytoma 01/2021

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 03/2021 - 03/2002
20	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 09/2005
18	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 12/2002
15	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 12/2002
14	Ifosfamide FDA LinkGeneric 01/2022 - 05/2005
11	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2011
9	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 09/2004
9	ParaffinIBA 06/2018 - 09/2004
7	TrabectedinIBA 01/2022 - 12/2002
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 02/2003
6	Messenger RNA (mRNA)IBA 06/2018 - 01/2002
6	Alkaline PhosphataseIBA 02/2017 - 12/2002
6	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2012 - 03/2002
5	AnthracyclinesIBA 01/2022 - 01/2018
5	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2012
5	Phosphotransferases (Kinase)IBA 11/2018 - 05/2005
5	Insulin-Like PeptidesIBA 01/2018 - 09/2006
5	AntibodiesIBA 01/2018 - 10/2009
5	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 05/2005
4	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 03/2010
4	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 12/2002
4	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 03/2004
3	Gemcitabine FDA Link 01/2020 - 01/2017
3	Caveolin 1IBA 01/2019 - 04/2006
3	Formaldehyde (Formol)FDA Link 01/2019 - 06/2016
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2005
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2017 - 06/2007
3	Complementary DNA (cDNA)IBA 01/2016 - 01/2002
3	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 12/2009
3	Insulin-Like Growth Factor I (IGF-1)IBA 09/2012 - 01/2004
3	NVP-AEW541IBA 09/2012 - 05/2005
2	mifamurtideIBA 06/2022 - 01/2022
2	multidrug resistance-associated protein 1IBA 12/2021 - 01/2014
2	Melphalan (Alkeran)FDA LinkGeneric 06/2021 - 01/2018
2	Busulfan (Busulfex)FDA Link 06/2021 - 01/2018
2	Denosumab FDA Link 01/2021 - 10/2018
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 07/2008
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 01/2010
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 11/2015
2	EWS-FLI fusion proteinIBA 05/2015 - 11/2014
2	ezrinIBA 01/2015 - 12/2009
2	Insulin ReceptorIBA 01/2015 - 09/2012
2	Everolimus FDA Link 01/2015 - 04/2013
2	Cytidine Diphosphate (CDP)IBA 11/2014 - 06/2012
2	Metformin (Glucophage)FDA LinkGeneric 01/2014 - 01/2013
2	Metalloproteases (Metalloproteinases)IBA 01/2014 - 03/2004
2	CollagenIBA 06/2013 - 01/2013
2	Sirolimus (Rapamycin)FDA Link 04/2013 - 01/2010
2	CaspasesIBA 04/2012 - 07/2004
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2011 - 08/2008
2	Dactinomycin (Actinomycin)FDA LinkGeneric 03/2010 - 05/2005
2	Succinic Acid (Succinate)IBA 02/2006 - 06/2005
1	AZD 6244IBA 12/2021
1	avapritinibIBA 12/2021
1	nilotinib FDA Link 12/2021
1	ripretinibIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 06/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2021
1	Chromogranin AIBA 03/2021
1	SynaptophysinIBA 03/2021

Therapy/Procedure

50	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
28	Neoadjuvant Therapy 01/2022 - 01/2004
26	Therapeutics 06/2022 - 07/2003
12	Radiotherapy 01/2020 - 10/2005
7	Adjuvant Chemotherapy 12/2016 - 07/2005
5	Surgical Amputation (Amputations) 01/2020 - 03/2005
3	Stem Cell Transplantation 06/2021 - 05/2003
3	Limb Salvage 02/2011 - 12/2005
2	Precision Medicine 01/2019 - 11/2015
2	Palliative Care (Palliative Therapy) 02/2011 - 02/2007
2	Aftercare (After-Treatment) 02/2007 - 12/2002
1	Metastasectomy 02/2023
1	Operative Surgical Procedures 10/2020